Next Article in Journal
Newborn Screening: Current Status in Alberta, Canada
Previous Article in Journal
Factors Influencing Parental Awareness about Newborn Screening
Previous Article in Special Issue
Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
Open AccessEditorial

Editorial for Special Issue “Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies”

Department of Child and Maternal Health, Clinic of Pediatric Hematology/Oncology, Azienda Ospedaliera-Università di Padova, 35129 Padova, Italy
Department of Pediatric Oncology/Hematology, Hospital Universitario General Gregorio Marañón, Facultad de Medicina, Universidad Complutense Madrid, 28007 Madrid, Spain
Laboratoire d’Excellence GR-Ex, UMR_S1134, Inserm, Université Paris Diderot, Sorbonne Paris Cité, Institut National de la Transfusion Sanguine, 75015 Paris, France
Department of Pediatric Hematology and Oncology, Gemeinschaftsklinikum Mittelrhein gGmbH, 56073 Koblenz, Germany
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2019, 5(4), 36;
Received: 17 September 2019 / Accepted: 17 September 2019 / Published: 20 September 2019
Note: In lieu of an abstract, this is an excerpt from the first page.

Sickle cell disease (SCD) is among the most common genetic disorders in the world, affecting over 300,000 newborns annually, with estimates for further increases to over 400,000 annual births within the next generation and with a wider geographical distribution of affected individuals due to global migration [...] View Full-Text
MDPI and ACS Style

Colombatti, R.; Cela, E.; Elion, J.; Lobitz, S. Editorial for Special Issue “Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies”. Int. J. Neonatal Screen. 2019, 5, 36.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop